ZA89628B - Paramagnetic compounds - Google Patents

Paramagnetic compounds

Info

Publication number
ZA89628B
ZA89628B ZA89628A ZA89628A ZA89628B ZA 89628 B ZA89628 B ZA 89628B ZA 89628 A ZA89628 A ZA 89628A ZA 89628 A ZA89628 A ZA 89628A ZA 89628 B ZA89628 B ZA 89628B
Authority
ZA
South Africa
Prior art keywords
paramagnetic compounds
paramagnetic
compounds
Prior art date
Application number
ZA89628A
Other languages
English (en)
Inventor
Jo Klaveness
Klaveness Jo
Paal Rongved
Rongved Paal
Per Strande
Strande Per
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of ZA89628B publication Critical patent/ZA89628B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA89628A 1988-01-26 1989-01-26 Paramagnetic compounds ZA89628B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888801646A GB8801646D0 (en) 1988-01-26 1988-01-26 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA89628B true ZA89628B (en) 1989-10-25

Family

ID=10630512

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89628A ZA89628B (en) 1988-01-26 1989-01-26 Paramagnetic compounds

Country Status (13)

Country Link
US (1) US5208324A (fr)
EP (2) EP0326226A1 (fr)
JP (1) JPH03502338A (fr)
CA (1) CA1331458C (fr)
DK (1) DK175390A (fr)
FI (1) FI903108A0 (fr)
GB (1) GB8801646D0 (fr)
HU (1) HU205212B (fr)
IE (1) IE890233L (fr)
NZ (1) NZ227750A (fr)
RU (1) RU2081881C1 (fr)
WO (1) WO1989006979A1 (fr)
ZA (1) ZA89628B (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
GB8900719D0 (en) * 1989-01-13 1989-03-08 Nycomed As Compounds
US5395608A (en) * 1989-04-26 1995-03-07 The Curators Of The University Of Missouri Triamine chelants, their derivatives, complexes and conjugates
NZ236267A (en) * 1989-12-22 1992-12-23 Squibb & Sons Inc 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
AU625529B2 (en) * 1989-12-22 1992-07-16 E.R. Squibb & Sons, Inc. 10-(2'-hydroxy-3'-alkoxy-1,4,7-triscarboxymethyl-1,4,7,10- tetraazacyclododecanes
JP3131219B2 (ja) * 1990-01-19 2001-01-31 ニユコメド・イメージング・アクシエセルカペト キレート化合物
US5236694A (en) * 1990-02-21 1993-08-17 The Board Of Regents, The University Of Texas System 19f labelled dextrans and antibodies as nmr imaging and spectroscopy agents
US5494655A (en) * 1990-03-09 1996-02-27 The Regents Of The University Of California Methods for detecting blood perfusion variations by magnetic resonance imaging
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
FR2663544B1 (fr) * 1990-06-26 1994-05-06 Medgenix Group Sa Agent de contraste pour l'imagerie par rmn et agents chelateurs comportant des structures peptidiques.
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5562894A (en) * 1991-08-09 1996-10-08 Regents Of The University Of California Amino-acyl-type and catecholamine-type contrast agents for MRI
JPH07502725A (ja) * 1991-08-09 1995-03-23 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Ｍｒｉ用のアミノ酸、エステルおよび／またはカテコール造影剤
AU663572B2 (en) * 1992-03-27 1995-10-12 Nihon Medi-Physics Co., Ltd. Tetraazacyclododecane derivative and its use
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
EP0665729B1 (fr) * 1992-09-04 2003-05-07 The General Hospital Corporation Polymeres biocompatibles contenant des fractions therapeutiques ou de diagnostic
US5871710A (en) * 1992-09-04 1999-02-16 The General Hospital Corporation Graft co-polymer adducts of platinum (II) compounds
US5756688A (en) * 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
US5817292A (en) * 1992-10-14 1998-10-06 Nycomed Imaging As MR imaging compositions and methods
US5401493A (en) * 1993-03-26 1995-03-28 Molecular Biosystems, Inc. Perfluoro-1H,-1H-neopentyl containing contrast agents and method to use same
US5811076A (en) * 1993-05-20 1998-09-22 The Regents Of The University Of California Macromolecular contrast media for MR imaging
US5605672A (en) * 1993-06-09 1997-02-25 The General Hospital Corporation Blood pool imaging composition and method of its use
US5814299A (en) * 1993-07-28 1998-09-29 Diatide, Inc. Radiolabeled glucans comprising a single thiol containing moiety
US5730968A (en) * 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents
IL115670A (en) * 1994-10-21 1999-11-30 Nihon Mediphysics Co Ltd Diagnostic imaging agent
US5602180A (en) * 1995-03-31 1997-02-11 World Health Group Method of administering EDTA complexes
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
NL1003776C2 (nl) * 1996-08-09 1998-02-20 Cooperatie Cosun U A Milieuvriendelijke complexanten voor zware metalen
US6045776A (en) * 1996-12-04 2000-04-04 Schering Aktiengesellschaft Process for the production of metal-complex carboxylic acid amides
DE19808079A1 (de) * 1998-02-20 1999-08-26 Schering Ag Hydroxyethylstärke-Konjugate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
WO2002096460A1 (fr) * 2001-05-30 2002-12-05 Cornell Research Foundation, Inc. Proteines de fusion endopeptidase/anticorps anti-psma servant au traitement du cancer
WO2002098897A2 (fr) 2001-06-01 2002-12-12 Cornell Research Foundation, Inc. Anticorps modifies diriges contre l'antigene prostatique specifique membranaire et utilisations associees
US7666414B2 (en) * 2001-06-01 2010-02-23 Cornell Research Foundation, Inc. Methods for treating prostate cancer using modified antibodies to prostate-specific membrane antigen
US7514078B2 (en) * 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
AU2002305767B2 (en) 2001-09-20 2008-04-10 Cornell Research Foundation, Inc. Methods and compositions for treating and preventing skin disorders using binding agents specific for PSMA
US20040136998A1 (en) * 2002-10-30 2004-07-15 Bander Neil H. Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen
AU2003293556A1 (en) 2003-01-10 2004-08-10 Millennium Pharmaceuticals, Inc. Methods of diagnosing and treating cancer
WO2005070456A2 (fr) * 2004-01-09 2005-08-04 Millennium Pharmaceuticals, Inc. Diagnostic et traitement du cancer
EP1610818A4 (fr) * 2004-03-03 2007-09-19 Millennium Pharm Inc Anticorps modifies diriges contre un antigene membranaire specifique de la prostate
US8669236B2 (en) 2005-05-12 2014-03-11 The General Hospital Corporation Biotinylated compositions
US20090258028A1 (en) * 2006-06-05 2009-10-15 Abbott Cardiovascular Systems Inc. Methods Of Forming Coatings For Implantable Medical Devices For Controlled Release Of A Peptide And A Hydrophobic Drug
US8323676B2 (en) * 2008-06-30 2012-12-04 Abbott Cardiovascular Systems Inc. Poly(ester-amide) and poly(amide) coatings for implantable medical devices for controlled release of a protein or peptide and a hydrophobic drug
DE102007002726A1 (de) 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US8765162B2 (en) * 2008-06-30 2014-07-01 Abbott Cardiovascular Systems Inc. Poly(amide) and poly(ester-amide) polymers and drug delivery particles and coatings containing same
US20100196272A1 (en) * 2009-01-30 2010-08-05 Neoprobe Corporation Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran
CA2836927A1 (fr) * 2011-06-21 2012-12-27 Immunogen, Inc. Nouveaux derives de maytansinoide comprenant un lieur peptidique et conjugues correspondants
JP6431480B2 (ja) 2012-08-31 2018-11-28 ザ ジェネラル ホスピタル コーポレイション アルツハイマー病の治療および診断のためのビオチン複合体
WO2018053460A1 (fr) * 2016-09-19 2018-03-22 The Regents Of The University Of California Polymères paramagnétiques
CA3046837A1 (fr) 2016-12-08 2018-06-14 The Brigham And Women's Hospital, Inc. Nanoparticules de bismuth-gadolinium
US11344638B2 (en) 2020-03-20 2022-05-31 Robert Norman Taub Composition for radiation treatment of intracavitary or metastatic deposits of malignancy and method for treatment therewith
FR3116197A1 (fr) * 2020-11-19 2022-05-20 Nh Theraguix Procédé de traitement de tumeurs par captation du cuivre et/ou du fer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE420565B (sv) * 1974-06-06 1981-10-19 Pharmacia Ab Hjelpmedel for intravaskuler administraring for anvendning i samband med intravaskuler administrering av en losning eller en suspension av ett diagnostiseringsmedel
DE3129906C3 (de) * 1981-07-24 1996-12-19 Schering Ag Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik
US4741900A (en) * 1982-11-16 1988-05-03 Cytogen Corporation Antibody-metal ion complexes
NL194579C (nl) * 1983-01-21 2002-08-05 Schering Ag Diagnostisch middel.
DE3324235A1 (de) * 1983-07-01 1985-01-10 Schering AG, 1000 Berlin und 4709 Bergkamen Neue komplexbildner, komplexe und komplexsalze
CA1243602A (fr) * 1983-08-25 1988-10-25 Hong-Ning Yeung Methode d'accentuation du contraste en imagerie a rmn
US4615879A (en) * 1983-11-14 1986-10-07 Vanderbilt University Particulate NMR contrast agents for gastrointestinal application
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
GB8413849D0 (en) * 1984-05-31 1984-07-04 Amersham Int Plc Nmr contrast agents
US4687659A (en) * 1984-11-13 1987-08-18 Salutar, Inc. Diamide-DTPA-paramagnetic contrast agents for MR imaging
US4687658A (en) * 1984-10-04 1987-08-18 Salutar, Inc. Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging
US4639365A (en) * 1984-10-18 1987-01-27 The Board Of Regents, The University Of Texas System Gadolinium chelates as NMR contrast agents
EP0184899B1 (fr) * 1984-11-01 1990-04-18 Nycomed As Agents de contraste paramagnétiques pour utilisation dans les méthodes de diagnostic par RMN "in vivo" et leur préparation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
AU6621586A (en) * 1985-11-18 1987-06-02 University Of Texas System, The Polychelating agents for image and spectral enhancement (and spectral shift)
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
DE3772785D1 (de) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-substituiertes-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecan und analoga.
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
US5057313A (en) * 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
FR2614020B1 (fr) * 1987-04-14 1989-07-28 Guerbet Sa Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands.
ATE137228T1 (de) * 1987-07-16 1996-05-15 Nycomed Imaging As Aminocarbonsäure und derivate
US5047227A (en) * 1988-02-08 1991-09-10 Cytogen Corporation Novel and improved antibodies for site specific attachment of compounds

Also Published As

Publication number Publication date
HU891057D0 (en) 1990-12-28
JPH03502338A (ja) 1991-05-30
DK175390A (da) 1990-09-20
WO1989006979A1 (fr) 1989-08-10
DK175390D0 (da) 1990-07-23
EP0396617B1 (fr) 1992-06-24
EP0396617A1 (fr) 1990-11-14
HUT55022A (en) 1991-04-29
NZ227750A (en) 1991-03-26
HU205212B (en) 1992-03-30
EP0326226A1 (fr) 1989-08-02
US5208324A (en) 1993-05-04
FI903108A0 (fi) 1990-06-20
IE890233L (en) 1989-07-26
RU2081881C1 (ru) 1997-06-20
CA1331458C (fr) 1994-08-16
GB8801646D0 (en) 1988-02-24

Similar Documents

Publication Publication Date Title
ZA89628B (en) Paramagnetic compounds
GB2222826B (en) Antisudoral compounds
GB8827308D0 (en) Compounds
GB8804448D0 (en) Compounds
GB8816944D0 (en) Compounds
GB8822144D0 (en) Compounds
GB8804444D0 (en) Compounds
EP0396620A4 (en) Aminomethyl-chroman and -thiochroman compounds
GB8804445D0 (en) Compounds
GB8804447D0 (en) Compounds
GB8822150D0 (en) Compounds
GB8804446D0 (en) Compounds
GB8812017D0 (en) Compounds
GB8802453D0 (en) Compounds
GB8803232D0 (en) Compounds
GB8803111D0 (en) Compounds
GB8803233D0 (en) Compounds
GB8803260D0 (en) Compounds
GB8803652D0 (en) Compounds
GB8804203D0 (en) Compounds
GB8808673D0 (en) Compounds
GB8809174D0 (en) Compounds
GB8811276D0 (en) Compounds
GB8811277D0 (en) Compounds
GB8803110D0 (en) Compounds